In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify cannabis like a Program III drug. This rescheduling will realize that cannabis has legitimate healthcare uses and may help open up the door to research on other opportunity treatment makes use of. From the pharmacological standpoint, https://thcdisposables.co.uk/